Learn more about our clinical services platform including:
- Fully integrated drug development services supporting preclinical and clinical needs,
up to regulatory approval and commercial phases - Clinical supply suitable from First in Human to Phase III, fully GMP-compliant and
with capacity to handle active ingredients classified up to OEB5 (OEL>0.5 µg/m³) - Additional capabilities such as API, formulation development, sample management, PK and statistical analyses, and metabolism